People have witnessed the recent redraw of some popular drugs due to their severe side effects. These drugs, of which Trasylol is an example, have been withdrawn from the market in order to put an end to severe complications that may appear after bypass surgery. Safety concerns have played a major role in these recalls and the recall class action attorney has become important in order to help patients protect their legal rights. An attorney will start the lawsuit that can compensate people for their current suffering or loss. If you have been affected by Trasylol used during your bypass surgery, you should consider hiring a Trasylol lawsuit attorney in order to help you to get compensation.
The class action lawsuit is different from other lawsuits; for instance, such a lawsuit will represent a group of individuals who were affected by the same drug or product in the same way. Actually, the wrong can come in the severe form of a physical harm that may be due to the Trasylol usage. It is well known that this anti-bleeding drug can increase the risks of developing future strokes, heart and kidneys failure. The Trasylol lawsuit attorney can fill the class-action suit on behalf of all the patients who were affected by this drug.
There are plenty of advantages when it comes to the class-action suit. The primary advantage resides in the fact that a group of people will be represented by the Trasylol lawsuit attorney. They will be provided with the opportunity to present their case in front of a court in order to be compensated for their suffering and loss. They will not have to file a separate suit by themselves; for instance, the severe side effects of this anti-bleeding drug can justify the necessity of hiring a recall class action attorney in order to take proper care of the whole matter without each of the affected patients having to file the separate lawsuits in order to get compensated.
The Food and Drug Administration approved Aprotinin in 1993, a drug marketed by Bayer as Trasylol. Until being withdrawn from the market, sales of Trasylol over the past several years had escalated to more than $600 million. Unfortunately, there are estimates that at least 10,000 patients may unnecessarily need kidney dialysis due to use of aprotinin during heart surgery. Many patients may have been injected with Trasylol to reduce blood loss during coronary artery bypass (CABG) surgery.
Patients who underwent heart surgery are largely unaware if Trasylol was used during their heart surgery. The decision to use aprotinin (Trasylol) was made by a patient’s treating doctor.
A recent study, published by the New England Journal of Medicine (NEJM) (2006) reported a connection between Trasylol and increased risk of renal (kidney) failure, myocardial infarction, heart failure or stroke in patients who have had heart surgery.
Aprotinin (Trasylol) affects the way in which blood clots. Trasylol is injected into patients who are undergoing open heart surgery. Excessive bleeding, during and after heart surgery, is a serious complication. Such bleeding exposes patients to multiple risks. Aprotinin (Trasylol) is primarily used during repeat coronary artery bypass surgery to reduce the amount of bleeding. The amount of blood transfusion required is reduced by using clotting medications including Trasylol.
The NEJM study concluded that two other generic drugs were available that are safer and less expensive than Trasylol. Neither of the generic drugs (Amicar and Cyklokapron) was associated with increased risk of kidney failure, heart attack or stroke.
•The generic Amicar cost per dose = $11 •The generic Cyklokapron cost per dose = $44 •Trasylol cost per dose = $1300.
So, if you have been affected by the side effects of this anti-bleeding drug, you should hire an attorney in order to get compensated for your suffering and loss. The class-action lawsuit could be the form of litigation in the future for Trasylol because this type of lawsuit is not likely to burden the court.
Trasylol heart surgery stroke lawsuit was created in order to compensate patients due to the side effects of this controversial heart surgery drug. Good medicine should be all about providing the patient with the best and safest drugs on the planet. Bayer’s popular Trasylol medication was recalled late in 2007 due to side effects linked with its use in bypass surgery patients. There are plenty of dangers and complications that are related to this drug and the people who are already suffering from its side effects should seek legal representation to protect their rights.
Bayer's Trasylol problems are growing as they face thousand of potential lawsuits following increasing reports of their heart surgery drug's side effects. Trasylol has recently been linked to a higher risk of kidney failure, heart attack, and death in the five years following a patient undergoing bypass heart surgery. In 1993 Trasylol (Aprotinin) was approved by the Federal Drug Administration. Aprotinin is manufactured by Bayer under the brand name Trasylol.
Most heart surgery patients and families of patients who died following bypass surgery don't know if they were given Trasylol during their open heart surgery. Many patients suffering from Trasylol side effects such as kidney failure or heart failure don't know if they were given Trasylol during their surgery because the heart medication was given during the bypass procedure.
Trasylol affects the way in which blood clots. It is given to open heart surgery patients to help prevent excessive bleeding. Trasylol is mainly used during repeat coronary artery bypass (CABG) surgery to reduce the amount of bleeding both during and after surgery. Until being pulled from the market late in 2007, the drug had been in use for 13 years and a million patients had received it. One of the most serious complications for bypass surgery patients is excessive bleeding. Clotting medications such as Trasylol reduce the amount of blood transfusion needed during surgery. In 2006 The New England Journal of Medicine (NEJM) published a study that reported Trasylol side effects with an increased risk of developing heart failure, kidney failure, myocardial infarction, and stroke in bypass heart surgery patients.
On September 21, 2006 the FDA's Cardiovascular and Renal Drug Advisory Committee met to discuss current data regarding Trasylol problems. On September 29, 2006, the FDA issued a public health advisory stating that it had new information that Bayer neglected to disclose an earlier study it had conducted involving 67,000 heart surgery patients. Preliminary review of this study suggested that Trasylol side effects included higher risks for stroke, congestive heart failure, kidney failure, and death. Bayer failed to disclose this study during the Advisory Committee on September 21, 2006.
Dr. Dennis Mangano, the lead author of the NEJM Trasylol side effects study, has noted that Trasylol problems occurred more frequently than those linked with the drug Vioxx. Dr. Mangano relates, "In fact our findings raise even more troubling concerns, for: (1) aprotinin has been on the market for three times as long as Vioxx, yet few comprehensive safety studies have been conducted since approval; (2) the life-threatening complications with aprotinin found here occurred far more frequently than those with Vioxx; and (3) far less expensive generic alternatives to aprotinin which are equally effective in limiting bleeding have been available, but have been underused."
The observational study concluded, "Our findings raise serious concerns regarding the safety of an approved drug intended to limit blood loss in at-risk patients undergoing surgery." Mangano related his opinion regarding the ongoing use of Trasylol, stating "In good conscience, I could not administer (Trasylol) to this group of patients, especially given the availability of safer alternatives." Trasylol problems continue to be studied and the number of patients affected by the drug continues to rise as the public becomes more aware of the drugs devastating side effects.
Jhoana Cooper has sinced written about articles on various topics from Football, Jokes and Business and Finance. can help you with your legal claims against the manufacturer. Therefore, you should consider hiring an. Jhoana Cooper's top article generates over 823000 views. to your Favourites.